false --12-31 0001715819 0001715819 2024-07-18 2024-07-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K/A

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 18, 2024

 

 

 

ELECTROMEDICAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware Commission File Number 82-2619815
(State or other jurisdiction of
incorporation or organization)		 000-56192 (I.R.S. Employer
Identification Number)

 

16561 N. 92nd Street, Ste. 101

Scottsdale, AZ 85260

 (Address of Principal Executive Offices and Zip Code) 

 

888-880-7888

(Issuer's telephone number)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbols Name of Exchange on Which Registered
COMMON EMED NONE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.03 - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

 

On August 6, 2024, the Board of Directors and a majority of the shareholders eligible to vote approved the cancelation of the Corporation's July 18, 2024, amendment to Section 4 of the Corporation’s Certificate of Incorporation to increase the total number of authorized shares to three billion, one million, and one share.

 

Instead, the Board and majority shareholders approved the following amendment to increase the total number of authorized shares to five billion, one million, and one, as follows:

 

Fourth: The aggregate number of shares that the Corporation is authorized to issue is Five Billion, One Million, and One (3,001,000,001), which includes:

 

·Common Stock: Five Billion (5,000,000,000) shares with a par value of $0.00001 per share.

 

·Series “A” Preferred Shares: One Million (1,000,000) shares with a par value of $0.00001 per share; and

 

·Series “B” Preferred Shares: One (1) share with a par value of $0.00001 per share.

 

The Certificate of Amendment is being processed by the Delaware Secretary of State and will be effective upon completion of the filing.

 

Section 9 – Financial Statement and Exhibits

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.  Document  Location
3.1  Certificate of Amendment  Filed Herewith
       
104  Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated August 9, 2024

 

ELECTROMEDICAL TECHNOLOGIES, INC.  
   
By: /s/ Matthew Wolfson  
Matthew Wolfson  
Chief Executive Officer  
(Principal Executive Officer)  

 

 

 

Exhibit 3.1

GRAPHIC

STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION The corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1. The name of the corporation is_________________________________________ _______________________________________________________________________. ________________________________________________________________________ ________________________________________________________________________ ________________________________________________________________________ 3. That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware. By:____________________________________ Authorized Officer Name:____________________________________ Print or Type Electromedical Technologies, Inc. $0.00001 per share, and One (1) share designated as “Series ‘B’ Preferred Shares, par value $0.00001 per share. Matthew Wolfson, President Docusign Envelope ID: FAF8ED16-AB80-4761-8B53-DF779B95A65B 2. The Certificate of Incorporation of the corporation is hereby amended by changing the Article thereof numbered _______ Fourth ________________________ so that, as amended, said Article shall be and read as follows: ____ Fourth_. ___________________________________________________________________ ____ The agg___________________ regate number of shares that th_ e_____________________________________ Corporation shall have the authority to issue is Five Billion, One _ M__________ illion, and One ____ (5,001_,00__________________ 0,001), including Five Billion ( _ 5, _____________________________________ 000,000,000) shares of capital stock designated as “Common S_to__________ ck,” with a ____ par va_lu__________________ e of $0.00001 per share, One M_i _____________________________________ llion (1,000,000) shares designated as “Series ‘A’ Preferred Sha_re__________ s,” par value 08/06/2024

v3.24.2.u1
Cover
Jul. 18, 2024
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag false
Document Period End Date Jul. 18, 2024
Current Fiscal Year End Date --12-31
Entity File Number 000-56192
Entity Registrant Name ELECTROMEDICAL TECHNOLOGIES, INC.
Entity Central Index Key 0001715819
Entity Tax Identification Number 82-2619815
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 16561 N. 92nd Street
Entity Address, Address Line Two Ste. 101
Entity Address, City or Town Scottsdale
Entity Address, State or Province AZ
Entity Address, Postal Zip Code 85260
City Area Code 888
Local Phone Number 880-7888
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security COMMON
Trading Symbol EMED
Security Exchange Name NONE
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more ElectroMedical Technolog... (PK) Charts.
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more ElectroMedical Technolog... (PK) Charts.